Kotak Quant Fund
The scheme seek to generate long term capital appreciation by investing predominantly in equity and equity related securities selected based on quant model theme.
Growthvine rating: 4/5 — ranked #35 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹14.64 (as of 2026-11-13) |
|---|
| AUM | ₹451 Cr |
|---|
| Expense ratio | 1.60% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Harsha Upadhyaya |
|---|
| Exit load | 0.5% for redemption within 90 days |
|---|
Performance & risk
| Sharpe ratio | 0.38 |
|---|
| Standard deviation | 17.90% |
|---|
| Max drawdown | −22.39% |
|---|
| Alpha | 1.31 |
|---|
| Beta | 1.08 |
|---|
Over 5 years, captured 66.6% of NIFTY Alpha 50's upside and 61.7% of its downside.
Market cap allocation
| Large cap | 29.1% |
|---|
| Mid cap | 27.3% |
|---|
| Small cap | 43.7% |
|---|
Concentration
| Top 5 holdings | 19.0% |
|---|
| Top 10 holdings | 34.1% |
|---|
| Total holdings | 45 |
|---|
Top holdings
- Apollo Hospitals Enterprises Ltd. — 4.8%
- Bajaj Auto Limited — 4.0%
- TVS Motor Company Ltd. — 3.6%
- Nestle India Ltd. — 3.3%
- Laurus Labs Limited — 3.3%
- Bosch Ltd — 3.2%
- Sona BLW Precision Forgings Limited — 3.1%
- Granules India Ltd. — 3.0%
- Radico Khaitan Ltd. — 2.9%
- Divis Laboratories Ltd. — 2.9%
Top sectors
- Pharma & Biotech — 17.9%
- Automobile — 16.1%
- Electricals — 9.6%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −4.5% | Q4 (Bottom) | #154 of 167 |
| 2025 | 3.9% | Q2 | #63 of 132 |
| 2024 | 18.6% | Q3 | #54 of 87 |